Your browser doesn't support javascript.
loading
Mathematical modelling of the influence of serosorting on the population-level HIV transmission impact of pre-exposure prophylaxis.
Wang, Linwei; Moqueet, Nasheed; Simkin, Anna; Knight, Jesse; Ma, Huiting; Lachowsky, Nathan J; Armstrong, Heather L; Tan, Darrell H S; Burchell, Ann N; Hart, Trevor A; Moore, David M; Adam, Barry D; Macfadden, Derek R; Baral, Stefan; Mishra, Sharmistha.
Affiliation
  • Wang L; MAP-Centre for Urban Health Solutions, St. Michael's Hospital, Unity Health Toronto.
  • Moqueet N; MAP-Centre for Urban Health Solutions, St. Michael's Hospital, Unity Health Toronto.
  • Simkin A; MAP-Centre for Urban Health Solutions, St. Michael's Hospital, Unity Health Toronto.
  • Knight J; MAP-Centre for Urban Health Solutions, St. Michael's Hospital, Unity Health Toronto.
  • Ma H; Institute of Medical Sciences, University of Toronto, Toronto, Ontario.
  • Lachowsky NJ; MAP-Centre for Urban Health Solutions, St. Michael's Hospital, Unity Health Toronto.
  • Armstrong HL; School of Public Health and Social Policy, University of Victoria, Victoria.
  • Tan DHS; British Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada.
  • Burchell AN; School of Psychology, University of Southampton, Southampton, UK.
  • Hart TA; MAP-Centre for Urban Health Solutions, St. Michael's Hospital, Unity Health Toronto.
  • Moore DM; Department of Medicine.
  • Adam BD; Institute of Health Policy, Management, and Evaluation.
  • Macfadden DR; MAP-Centre for Urban Health Solutions, St. Michael's Hospital, Unity Health Toronto.
  • Baral S; Department of Family and Community Medicine.
  • Mishra S; Dalla Lana School of Public Health, University of Toronto.
AIDS ; 35(7): 1113-1125, 2021 06 01.
Article in En | MEDLINE | ID: mdl-33534205
OBJECTIVES: HIV pre-exposure prophylaxis (PrEP) may change serosorting patterns. We examined the influence of serosorting on the population-level HIV transmission impact of PrEP, and how impact could change if PrEP users stopped serosorting. DESIGN: We developed a compartmental HIV transmission model parameterized with bio-behavioural and HIV surveillance data among MSM in Canada. METHODS: We separately fit the model with serosorting and without serosorting [counterfactual; sero-proportionate mixing (random partner-selection proportional to availability by HIV status)], and reproduced stable HIV epidemics with HIV-prevalence 10.3-24.8%, undiagnosed fraction 4.9-15.8% and treatment coverage 82.5-88.4%. We simulated PrEP-intervention reaching stable pre-specified coverage by year-one and compared absolute difference in relative HIV-incidence reduction 10 years post-intervention (PrEP-impact) between models with serosorting vs. sero-proportionate mixing; and counterfactual scenarios when PrEP users immediately stopped vs. continued serosorting. We examined sensitivity of results to PrEP-effectiveness (44-99%; reflecting varying dosing or adherence levels) and coverage (10-50%). RESULTS: Models with serosorting predicted a larger PrEP-impact than models with sero-proportionate mixing under all PrEP-effectiveness and coverage assumptions [median (interquartile range): 8.1% (5.5-11.6%)]. PrEP users' stopping serosorting reduced PrEP-impact compared with when PrEP users continued serosorting: reductions in PrEP-impact were minimal [2.1% (1.4-3.4%)] under high PrEP-effectiveness (86-99%); however, could be considerable [10.9% (8.2-14.1%)] under low PrEP effectiveness (44%) and high coverage (30-50%). CONCLUSION: Models assuming sero-proportionate mixing may underestimate population-level HIV-incidence reductions due to PrEP. PrEP-mediated changes in serosorting could lead to programmatically important reductions in PrEP-impact under low PrEP-effectiveness. Our findings suggest the need to monitor sexual mixing patterns to inform PrEP implementation and evaluation.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / Anti-HIV Agents / Pre-Exposure Prophylaxis / Sexual and Gender Minorities Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans / Male Country/Region as subject: America do norte Language: En Journal: AIDS Journal subject: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Year: 2021 Document type: Article Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / Anti-HIV Agents / Pre-Exposure Prophylaxis / Sexual and Gender Minorities Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans / Male Country/Region as subject: America do norte Language: En Journal: AIDS Journal subject: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Year: 2021 Document type: Article Country of publication: United kingdom